EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
Frontiers of Science: Prof. Hans Clevers
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
Immunology Seminar Series, Sollid
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
Doctoral defence: MSc Maria Jaakkola, May 6th 2022
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
The Academy of Finland awarded Academy Research Fellow position to Alex Dickens and Academy postdoctoral researcher positions to Lili Li and Lea Mikkola
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
Frontiers of Science: Prof. Christopher S. Chen
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
New insights into regulation of immune response
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
Immunology seminar, Sollid
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
BioCity Turku Collaborative Research Funding Call 2022
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…
Frontiers of Science: Prof. Cheryl Kerfeld
EVENT EVENT Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer…